Arcutis Biotherapeutics, Inc. (ARQT)
31.20
-1.00
(-3.11%)
USD |
NASDAQ |
Oct 23, 16:00
31.20
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value : 17.76 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 17.76 |
| October 22, 2026 | 18.33 |
| October 21, 2026 | 18.15 |
| October 20, 2026 | 18.69 |
| October 19, 2026 | 18.16 |
| October 16, 2026 | 16.41 |
| October 15, 2026 | 16.57 |
| October 14, 2026 | 15.04 |
| October 13, 2026 | 14.85 |
| October 12, 2026 | 14.93 |
| October 09, 2026 | 15.13 |
| October 08, 2026 | 13.94 |
| October 07, 2026 | 13.76 |
| October 06, 2026 | 13.62 |
| October 05, 2026 | 14.32 |
| October 02, 2026 | 14.33 |
| October 01, 2026 | 14.40 |
| September 30, 2026 | 15.05 |
| September 29, 2026 | 15.23 |
| September 28, 2026 | 15.56 |
| September 25, 2026 | 15.33 |
| September 24, 2026 | 14.96 |
| September 23, 2026 | 15.02 |
| September 22, 2026 | 15.82 |
| September 21, 2026 | 14.78 |
| Date | Value |
|---|---|
| September 18, 2026 | 14.45 |
| September 17, 2026 | 15.07 |
| September 16, 2026 | 14.88 |
| September 15, 2026 | 13.39 |
| September 14, 2026 | 13.82 |
| September 11, 2026 | 13.60 |
| September 10, 2026 | 13.31 |
| September 09, 2026 | 13.57 |
| September 08, 2026 | 13.89 |
| September 04, 2026 | 13.61 |
| September 03, 2026 | 13.47 |
| September 02, 2026 | 13.58 |
| September 01, 2026 | 13.52 |
| August 31, 2026 | 13.65 |
| August 28, 2026 | 13.54 |
| August 27, 2026 | 14.16 |
| August 26, 2026 | 14.31 |
| August 25, 2026 | 14.15 |
| August 24, 2026 | 14.11 |
| August 21, 2026 | 14.28 |
| August 20, 2026 | 14.43 |
| August 19, 2026 | 15.07 |
| August 18, 2026 | 15.11 |
| August 17, 2026 | 14.58 |
| August 14, 2026 | 14.91 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Insmed, Inc. | 26.91 |
| Emergent BioSolutions, Inc. | 0.9361 |
| Exelixis, Inc. | 8.711 |
| Puma Biotechnology, Inc. | 4.065 |
Price to Book Value Related Metrics
| PE Ratio | 150.65 |
| PS Ratio | 8.973 |
| Price to Free Cash Flow | 106.34 |
| Price | 31.20 |
| Earnings Yield | 0.66% |
| Market Cap | 3.918B |
| Operating PE Ratio | 121.55 |
| Normalized PE Ratio | 150.36 |